In contrast, Ag/sIgM and sialidase-treated Ag/sIgM induced a simi

In contrast, Ag/sIgM and sialidase-treated Ag/sIgM induced a similar level of the BCR signaling in control cells (K46μvCD72). These results imply that CD22 activation is augmented by glycan ligand on sIgM. Next, we examined whether Ag/sIgM regulates buy MI-503 CD22 activation in trans. Ag/sIgM induced CD22 phosphorylation and subsequent recruitment of SHP-1 more

efficiently than sialidase-treated Ag/sIgM (Fig. 3A). Furthermore, CD22 preferentially coprecipitated with Ag/sIgM but not sialidase-treated Ag/sIgM, suggesting that CD22 physically binds to sIgM in an α2,6Sia-dependent manner (Fig. 3B). Membrane IgM (mIgM) also coprecipitated with Ag/sIgM regardless of sialidase-treatment. This interaction is probably mediated by Ag. Immunoprecipitation of SHP-1/SHIP-1 revealed that CD22 appears to be a major phospho-protein upon BCR cross-linking by Ag/sIgM (Supporting Information Fig. 3A). Moreover, FcγRIIB, an inhibitory Fc receptor for IgG on B cells seems not to be activated by sIgM because its recruitment of SHIP-1 did not increase by Ag/sIgM as was the case for NP-BSA (Supporting Information Fig. 3B). These results strongly suggest that Ag/sIgM induces a negative feedback loop

for BCR signaling via CD22 in trans in a glycan ligand-dependent manner, ABT 888 most likely by coligation of CD22 with BCR (Fig. 3C). CD22 on B cells cannot bind to sIgM with different Ag specificities and sIgM cannot bind to CD22 on α2,6Sia-expressing cells (Fig. 1). However, when the BCR bears the same Ag specificity as sIgM, the interaction of the BCR with Ag/sIgM may bring CD22 and sIgM into proximity, resulting in the coligation of BCR and CD22 via Ag/sIgM. Thus, Ag/sIgM

complexes induce CD22 activation and trigger a negative feedback loop for B-cell Galeterone activation, as is the case for the FcγRIIB 19–21. These molecular mechanisms prevent autoimmunity and excess immunity depending on the quality and quantity of Ags, i.e. size and valency. When excess amounts of Abs exist, Ags are heavily covered by Abs to induce complement activation, resulting in clearance of Ags by phagocytes without B-cell activation. However, under some circumstances Ag/sIgM complexes that induce either immunity or tolerance are generated. If a relatively large Ag can induce a conformational change in sIgM, complement is activated by the C3d(g)/IgM/Ag interaction. This results in the induction of positive feedback for B-cell activation via the complement receptor CR2/CD21, which is associated with the positive regulatory molecule CD19 22. Small Ags that do not evoke a conformational change in sIgM do not activate complement, instead Ag/sIgM complexes may induce negative feedback for B-cell activation via CD22 as shown in Fig. 3C. Recently, FcμR on B cells has been identified 23, 24. However, this receptor is undetectable on freshly isolated spleen B cells and its expression is upregulated by BCR stimulation or special culture conditions.

Comments are closed.